Stuart A Weinzimer
Overview
Explore the profile of Stuart A Weinzimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
5908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turk Yilmaz R, Hittelman A, Vash-Margita A, Dinauer C, Weinzimer S, Gujral J
JCEM Case Rep
. 2024 Dec;
3(1):luae239.
PMID: 39726663
46,XY sex reversal 11 (SRXY11) is a rare and recently identified form of 46,XY difference in sexual development (DSD), caused by variants in the DEAH-Box Helicase 37 gene (). is...
2.
Ash G, Nam S, Stults-Kolehmainen M, Haughton A, Turek C, Chmielewski A, et al.
medRxiv
. 2024 Jul;
PMID: 39006443
Background: Barriers to moderate-to-vigorous physical activity (MVPA) for adolescents with type 1 diabetes (T1D) include physiology, transition to autonomy, and diabetes-specific stigma. Opportunities for T1D peer activities with T1D role...
3.
Fox D, Ware J, Boughton C, Allen J, Wilinska M, Tauschmann M, et al.
J Diabetes Sci Technol
. 2024 Mar;
:19322968241231950.
PMID: 38494876
Background/objective: The main objective of this study is to evaluate the incremental cost-effectiveness (ICER) of the Cambridge hybrid closed-loop automated insulin delivery (AID) algorithm versus usual care for children and...
4.
Addala A, Weinzimer S
Diabetes Technol Ther
. 2024 Mar;
26(S1):S187-S200.
PMID: 38441450
No abstract available.
5.
Hughes A, Chapman K, Nguyen H, Liu J, Bispham J, Winget M, et al.
Clin Diabetes
. 2023 Jul;
41(3):399-410.
PMID: 37456102
Severe hypoglycemia (SH) is the most frequent and potentially serious complication affecting individuals with type 1 diabetes and can have major clinical and psychosocial consequences. Glucagon is the only approved...
6.
Messer L, Addala A, Weinzimer S
Diabetes Technol Ther
. 2023 Feb;
25(S1):S176-S190.
PMID: 36802191
No abstract available.
7.
Ash G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, et al.
Clin J Sport Med
. 2023 Jan;
33(5):512-520.
PMID: 36715983
Objective: Pilot-test personalized digital health information to substantiate human-delivered exercise support for adults with type 1 diabetes (T1D). Design: Single-group, 2-week baseline observation, then 10-week intervention with follow-up observation. Setting:...
8.
Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, et al.
J Diabetes
. 2022 Dec;
15(1):71-75.
PMID: 36562281
Highlights Our study suggests that people with diabetes (PWD) face issues of affording and obtaining insulin and diabetes supplies, even in a population predominantly on private health insurance. Financially independent...
9.
Battelino T, Alexander C, Amiel S, Arreaza-Rubin G, Beck R, Bergenstal R, et al.
Lancet Diabetes Endocrinol
. 2022 Dec;
11(1):42-57.
PMID: 36493795
Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA as the measure of average blood glucose levels for the...
10.
Commissariat P, Volkening L, Weinzimer S, Dassau E, Laffel L
Can J Diabetes
. 2022 Oct;
47(1):66-72.
PMID: 36184368
Objectives: Teens and young adults with type 1 diabetes (T1D) often demonstrate difficulty with diabetes management, as they struggle to navigate the impact of T1D on their identities---their self-concepts, bodies,...